Metabolic exchange may define adaptation to the changes imposed by microbial interactions. We found 20 that antifungal activity of cell-free supernatants of Bacillus subtilis ALBA01 is acquired after interacting with 21 the soil fungus Setophoma terrestris (ST). Here we evaluated different traits of B. subtilis ALBA01 before 22 (pre-ST) and after (post-ST) interacting with the fungus in co-cultures and inquired about the molecular 23 mechanisms underlying this inter-kingdom interaction dependent antagonistic activity. Apart from the high 24 fungal inhibition activity, we observed that the ability to form robust biofilms in vitro was a prevailing feature 25 of post-ST and that biofilm formation was positively correlated to biocontrol efficacy. Moreover, nuclear 26 magnetic resonance and mass spectrometry analysis revealed a differential metabolomics profile in post-
compounds that would inhibit rather than stimulate cellular differentiation in B. subtilis, we observed that 116 both pre and post-ST variants were capable of forming floating biofilms (pellicles) characteristically 117 associated with biofilm formation in LBGM medium (31) . However, the pre-ST variants formed a more 118 featureless biofilm with slightly thinner pellicles that easily disintegrate (Figure 2A) . In contrast, the post-ST 119 variants were able to develop into more wrinkled and thicker pellicles, which is consistent with a robust 120 biofilm formation (Figure 2A ). We also evaluated the ability of the B. subtilis variants to form submerged showing full swarming motility ( Figure 2C ). Remarkably, when re-inoculated onto a fresh growth medium 125 (passaging) the post-ST variants still maintained not only the structured colony morphology but also the 126 increased capacity of biofilm formation, indicating that B. subtilis experiences a genetic stable phenotypic 127 variation after co-culture with S. terrestris.
128
The interaction between S. terrestris and B. subtilis ALBA01 results in differential secondary 129 metabolite profile in post-ST variants
130
To gain deeper understanding on the differential antifungal activity observed in the cell-free supernatants between both groups ( Figure S1b ). To visualize the differences between classes, we generated S-line plots 142 in OPLS-DA models and observed different signals that represent discriminant metabolites between both 143 BsA01 pre-ST and post-ST groups of samples ( Figure 3B ), all or some of which might constitute the factors 144 responsible for the antagonistic antifungal behavior.
145
We then compared the chemotypes of whole cells of BsA01 pre and post-ST variants to test whether the 146 metabolome is significantly altered between both variants. We carried out a non-targeted liquid 147 chromatography tandem mass spectrometry (LC-MS/MS) based metabolomics analysis and observed a 148 clear separation in the global metabolome between the variants in a Principal Coordinate Analysis (PCoA) 149 ( Figure 4A ). According to random forest analysis, lipopetides surfactin and plipastatin appeared to be the 150 most important variables that determine the difference between pre-and post-ST variants ( Figure 4B ).
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Intriguingly, the post-ST variants showed a marked reduction in the intensity of surfactin ions (m/z 1008.66; 152 1022.67; 1036.69; 1044.65; 1058.67) and also a decrease in the intensity of peaks with masses indicative 153 of the plipastatin ( Figure 4C and D, respectively), both of which were identified through spectrum library 154 matching and spectral networking (32, 33) . Moreover, the post-ST variants clustered together with a B.
155
subtilis NCBI 3610 surfactin-defective mutant, highlighting the role of surfactin in the separation between 156 the groups ( Figure 4A ). Figure S2 shows the molecular network obtained by analysis of the chemical profile 157 of the BsA01 variants. The pie charts in the network indicate relative abundances of ion features between 158 the different groups. The molecular networks indicate that not only the known surfactin and plipastatin 159 derivatives were diminished in post-ST variants but also other related unknown derivatives. In a second 160 approach, we applied LC-MS/MS based metabolomics to analyze cell-free supernatants of the BsA01 pre 161 and post-ST variants. In accordance with the results found for the whole bacterial cell analysis, we observed 162 a clear discrimination according to the origin of the cell-free supernatants with PcoA plots showing that 163 post-ST samples clustered separated from pre-ST variants ( Figure 5A ). Moreover, for post-ST cell-free 164 supernatants we could not detect surfactin ( Figure 5B ) nor plipastatin ( Figure 5C ) ions in levels comparable 165 to those found in the pre-ST variant of B. subtilis ALBA01 strain. Consistent with this, we also found that 166 post-ST variants did not show hemolytic activity ( Figure 5D ). Taking together, these results indicate that 167 what separates the post-ST variants most is the absence/decrease of the antimicrobial compounds 168 surfactin and plipastatin. In this sense, the abrogation of surfactin production in the post-ST variants is even most interesting since this lipopeptide can be considered a key player in environmental adaptation 170 processes, quorum-sensing and biofilm formation in B. subtilis.
171
Biofilm is positively correlated with the antifungal activity of cell-free supernatants 172 So far, our findings suggest that the biofilm formation and the absence of the lipopetide surfactin have a 173 role in the antagonistic behavior of the post-ST variants. Biofilm formation depends on the synthesis of 174 extracellular matrix, whose production is regulated by two major operons: the epsA-epsO and the tapA, 175 both under the control of the transcriptional repressor and biofilm master regulator SinR (34, 35) . On the 176 other hand, surfactin, which is involved in swarming motility and also acts as an antimicrobial metabolite (9, 177 36), has been identified as a communication signal that triggers biofilm formation (6, 28) . To test if key 178 genes involved in biofilm formation and surfactin production are related to the antifungal activity acquired 179 by post-ST variants, we generated two BsA01 mutants: a hyper robust biofilm-forming ΔsinR and a 180 surfactin-defective producer ΔsrfAA. The activity of the BsA01 mutants against S. terrestris was screened 181 by 15-day co-cultures on PDA dishes before and after which samples of each mutant were recovered and 182 tested. When cell-free supernatants of ΔsinR pre-ST mutant were examined for antifungal activity, although 183 lower than BsA01 pre-ST variant, it displayed a significantly higher activity than cell-free supernatants 184 obtained from ΔsinR post-ST cells ( Figure 6 ). While this result suggest that there is a positive correlation 185 between biofilm formation and antagonism, the mere activation of the biofilm pathway cannot completely 186 explain the ST-driven behavior of BsA01. On the contrary, antifungal activity differences between pre-ST 187 and post-ST supernatants disappeared when the ΔsrfAA surfactin-less mutant was analysed ( Figure 6 ).
188
Moreover, the absence of surfactin per se led to the acquisition of an equalled mycelium growth inhibitory 189 activity with respect to the BsA01 post-ST variants that previously interacted with the fungus (Figure 6 ).
190
The inability to produce and release surfactin not only resulted in an enhanced level of antagonism towards 191 ST but also in a total suppression of the ST-driven phenomenon.
192

B. subtilis post-ST variant undergoes a mutation-based phenotypic variation 193
To gain insight into the mechanisms underlying the specific and stable phenotypic variation in B. subtilis 194 ALBA01 directed by the interaction with S. terrestris, we decided to sequence the whole genome of three different post-ST variants (post-ST1, post-ST2 and post-ST3), which were independently derived from the 196 ALBA01 strain that was taken as a pre-ST ancestor and used as a reference. Reads from each post-ST 197 variant were aligned against the ALBA01 genome (NCBI Bioproject PRJNA316980) to assess the genetic 198 changes accumulated in post-ST during the interaction with the fungus. Overall the complete genomes, we 199 found between one and three different mutations in coding sequence regions for post-ST variants ( Table   200   1) . Surprisingly, each one of them carried at least one mutation in genes of the ComQXPA quorum-sensing 201 system. Among these, we found that post-ST 1 and post-ST 2 variants hold a mutation in the coding 
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and within this the DNA binding domain (171 to 190). According to prediction analysis by InterPro (37), the 212 +1A415 mutation may lead to a truncated version of the protein that lost the expected DNA-binding domain.
213
On the other hand, the mutation in the comP gene in post-ST3 variant consisted of a 100 bp-deletion at 214 position 632 of the gene and is predicted to cause the loss of the complete histidine kinase domain of the 215 protein. It is important to mention that the presence of these mutations was confirmed by PCR amplification 216 of comA and comP followed by direct sequencing. We then aimed to explore the involvement of com 217 mutations in the post-ST phenotype and to inquire to what extent com genes could be mutated in BsA01 218 after interacting with S. terrestris. For that, we conducted a whole-genome sequencing of a pool of 15 B.
219
subtilis post-ST variants independently obtained after interaction with the fungus in co-culture (Pool-seq).
220
To identify allelic variations in the pool, we first mapped the sequence reads to the reference genome (B.
221
subtilis ALBA01, NCBI Bioproject PRJNA316980) and then performed the variant calling (see Material and of post-ST variants, revealing a marked convergence of mutation within these genes that might explain the 224 metabolomics changes observed. Remarkably, we found the previously described comA insertional 225 mutation and also three new mutations in comA, two substitutions, T215A and C601T, and one 5 226 nucleotide-insertion at position 299 ( Table 2 ). The T215A mutation generated a premature stop codon at 
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Remarkably, the antagonistic behavior of BsA01 is manifested in cell-free supernatants of cells previously grown in the presence of the fungus (post-ST variants) but not in cells never exposed to the fungus (pre-
251
ST variants), indicating that the interaction with S. terrestris promotes a bacterial transformation that leads 252 to the secretion of antifungal factors. In this work, we aimed to understand this phenomenon through an 253 exhaustive characterization of BsA01 post-ST variants that included phenotypic, genetic, genomics and 254 metabolomics analysis. We present evidences that after 15 days of co-culture with S. terrestris, BsA01 surfactin derivative mutant suggesting that key differences between the BsA01 variants might rely on the 267 synthesis of surfactin. Surfactin is a heptapeptide linked to a fatty acid via a cyclic lactone ring structure 268 that is capable of inserting itself into cellular membranes where interacts with its lipid moiety leading to the 269 loss of membrane barrier properties and eventually resulting in its complete disintegration by a detergent-270 type mechanism (39). It has been widely reported that surfactin displays a significant antimicrobial activity 271 (9, 40). However, we found that the BsA01 post-ST variants show enhanced activity against the onion 272 pathogen S. terrestris but the biocontrol properties of the cell-free supernatant seemed to be independent 273 of surfactin in our study model. Most striking, B. subtilis appeared to have suppressed or reduced to a 274 minimum level the production of this classical antimicrobial lipopeptide after interacting with the fungus.
275
One could think that the lack of surfactin is a mere consequence of the metabolic change that arise along 276 with the phenotype variation experienced by BsA01 and that is not directly related to the antagonism per 277 se. However, it has been suggested that surfactins could interfere with the activity of other lipopeptides with proven antifungal activity such as fengycins/plipastatins and iturins (38, 41) . In a study, B.
279
amyloliquefaciens FZB42 mutants selectively repressed in the synthesis of one or two types of lipopeptides 280 revealed that the co-production of surfactin and fengycin lowered the global antifungal activity (38). Such 281 an effect of mixed lipopeptides was previously observed against the fungus Verticillium dahliae 282 (42). Moreover, a Bacillus subtilis subsp. krictiensis surfactin-less mutant showed significantly higher 283 antifungal activity against Fusarium oxysporum than its wild-type strain (41). Thus, we speculate that by 284 reducing or preventing the biosynthesis of surfactin, BsA01 could avoid some negative impact on fitness 285 while making an effective use of other inhibitory compounds against S. terrestris. However, we also found 286 that of the main differences between pre and post-ST variants is a strong reduction in plipastatin abundance 
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It has been described that Bacillus subtilis 916 strain was an effective biocontrol agent against the rice 315 pathogen Rhizoctonia solani and that a mutant version of this strain, artificially obtained by means of low-316 energy ion implantation, carries three missense mutations within the comA gene that the authors discuss 317 to be the cause of the lower levels of surfactin produced by the mutant. However, in this work in opposition 318 to what we observe, the reduction in surfactin production leads to a non-optimal performance of B. subtilis 319 916 against the fungus (47). Bacillus subtilis has an average of 4-5% of its genome devoted to antibiotic 320 synthesis and has the potential to produce more than two dozens of structurally diverse antimicrobial 321 compounds. More than 10% of its genome is controlled by the sophisticated ComQXPA quorum sensing 322 system centered on the transcriptional regulator, ComA. It has also been found that numerous genes with 323 unknown function were also affected by ComA (18). As mentioned before, the abrogation of surfactin in 324 post-ST variants might be explained by a loss-of-function of mutations in the comA gene. But, how could 325 mutations in comQXPA genes explain the reduction in the production of plipastatin also observed in the 326 post-ST variants? ComQXPA system has also been described to be involved in the transcription of the 327 pleiotropic regulator DegQ, which controls the production of degradative enzymes and is necessary for 328 plipastatin production (21, 48, 49) . Thus, we hypothesize that the reduction in plipastatin might represent 329 an indirect effect of the mutations in comA and comP genes through alteration in degQ expression. 
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Taken together, our findings allows us to speculate that the mutation found in the ComQXPA system of B.
343
subtilis post-ST variants may be involved in a regulatory mechanism that leads to the activation of a cryptic 344 biosynthetic pathway, which specifically responds to extracellular signals involved in the interaction 345 between the B. subtilis strain and S. terrestris in co-cultures. Future investigations will be necessary to 346 expand our knowledge on the identity and the role that the antagonistic metabolites play in this iteraction-347 driven evolution process. 
